SCHEMBL7319040

SCHEMBL7319040

O=[N+]([O-])c1ccc(N/N=C(\Cl)c2nccs2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 14/20 0.47
KMT2A Q03164 11/20 0.47
MEN1 O00255 10/20 0.47
NPSR1 Q6W5P4 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
MMP14 P50281 1/20 0.47
NPC1 O15118 4/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45
GAA P10253 7/20 0.43
ALDH1A1 P00352 6/20 0.43
HTT P42858 4/20 0.43
MAPK1 P28482 2/20 0.43
GFER P55789 2/20 0.43
SMN1; SMN2 Q16637 5/20 0.42
THRB P10828 3/20 0.42
ALOX12 P18054 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HSP90AA1 P07900 1/20 0.42
RAB9A P51151 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7319047 1.00 MAPT (0.47) MAPTKMT2AMEN1NPSR1TDP1
SCHEMBL14832051 0.76 L3MBTL1 (0.53) MAPTKMT2AMEN1NPSR1TDP1
SCHEMBL14832052 0.76 L3MBTL1 (0.53) MAPTKMT2AMEN1NPSR1TDP1
SCHEMBL7319559 0.75 KDR (0.55) MAPTKMT2AMEN1NPSR1TDP1
SCHEMBL7319562 0.75 KDR (0.55) MAPTKMT2AMEN1NPSR1TDP1
SCHEMBL7319081 0.73 ALDH1A1 (0.56) MAPTKMT2AMEN1NPSR1TDP1
SCHEMBL7319072 0.73 ALDH1A1 (0.56) MAPTKMT2AMEN1NPSR1TDP1
SCHEMBL19244894 0.71 MAPT (0.70) MAPTKMT2AMEN1NPSR1TDP1
SCHEMBL7328870 0.71 MEN1 (0.55) MAPTKMT2AMEN1NPSR1TDP1
SCHEMBL7328874 0.71 MEN1 (0.55) MAPTKMT2AMEN1NPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 MAPT 2674/4885KMT2A 3552/4885MEN1 1025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.